safer < safety < saharan

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by safety

Number of relevant bibliographic references: 55.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000187 (2020)	Nathan Ford ; Marco Vitoria ; Ajay Rangaraj ; Susan L. Norris ; Alexandra Calmy ; Meg Doherty	Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID‐19: initial assessment
000252 (2020)	Rong Chen [République populaire de Chine] ; Yuan Zhang [République populaire de Chine] ; Lei Huang [République populaire de Chine] ; Bi-Heng Cheng [République populaire de Chine] ; Zhong-Yuan Xia [République populaire de Chine] ; Qing-Tao Meng [République populaire de Chine]	Safety and efficacy of different anesthetic regimens for parturients with COVID-19 undergoing Cesarean delivery: a case series of 17 patients
000713 (2020)	Shibo Jiang	Don't rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees.
000778 (2020)	Le Chang [République populaire de Chine] ; Ying Yan [République populaire de Chine] ; Lunan Wang [République populaire de Chine]	Coronavirus Disease 2019: Coronaviruses and Blood Safety
000812 (2020)	D. Fernandez-Nieto [Espagne] ; D. Ortega-Quijano [Espagne] ; G. Segurado-Miravalles [Espagne] ; C. Pindado-Ortega [Espagne] ; M. Prieto-Barrios [Espagne] ; J. Jimenez-Cauhe [Espagne]	Comment on: Cutaneous manifestations in COVID-19: a first perspective. Safety concerns of clinical images and skin biopsies.
000847 (2020)	Cornelis Smit [Suisse] ; Mariska Y M. Peeters [Pays-Bas] ; John N. Van Den Anker [Suisse] ; Catherijne A J. Knibbe [Pays-Bas]	Chloroquine for SARS-CoV-2: Implications of Its Unique Pharmacokinetic and Safety Properties.
000A19 (2020)	Andrea Cortegiani [Italie] ; Giulia Ingoglia [Italie] ; Mariachiara Ippolito [Italie] ; Antonino Giarratano [Italie] ; Sharon Einav [Israël]	A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19.
001505 (2015)	S. L. Stramer [États-Unis] ; R. Y. Dodd [États-Unis] ; C. Y. Chiu [États-Unis]	Advances in testing technology to ensure transfusion safety – NAT and beyond
001761 (2014)	C. K. Lin [République populaire de Chine, Hong Kong] ; J. N. S. Leung [République populaire de Chine] ; B. K. L. So [République populaire de Chine] ; C. K. Lee [République populaire de Chine]	Donor selection for blood safety: is it still necessary?
001A65 (2013)	Zheng-Jun Guan [République populaire de Chine] ; Bin Guo [République populaire de Chine] ; Yan-Lin Huo [République populaire de Chine] ; Zheng-Ping Guan [République populaire de Chine] ; Jia-Kun Dai [République populaire de Chine] ; Ya-Hui Wei [République populaire de Chine]	Recent advances and safety issues of transgenic plant-derived vaccines
001C94 (2012)	Guanghua Qiao [République populaire de Chine] ; Ting Guo [République populaire de Chine] ; K. K. Klein [Canada]	Melamine and other food safety and health scares in China: Comparing households with and without young children
001D20 (2012)		Food Safety: At the Center of a One Health Approach for Combating Zoonoses
001E49 (2012)	Albrecht Gröner [Allemagne] ; Thomas Nowak [Allemagne] ; Wolfram Sch Fer [Allemagne]	Pathogen safety of human C1 esterase inhibitor concentrate
002098 (2011)	Karen P. Phillips [Canada] ; Tracey L. O'Sullivan ; Darcie Dow ; Carol A. Amaratunga	Infectious respiratory disease outbreaks and pregnancy: occupational health and safety concerns of Canadian nurses.
002289 (2011)	Chintamani Atreya ; Hira Nakhasi ; Paul Mied ; Jay Epstein ; James Hughes ; Marta Gwinn ; Steven Kleinman ; Roger Dodd ; Susan Stramer ; Mark Walderhaug ; Peter Ganz ; Raymond Goodrich ; Clark Tibbetts ; David Asher	FDA workshop on emerging infectious diseases: evaluating emerging infectious diseases (EIDs) for transfusion safety
002B11 (2009)	Albert Farrugia [Australie]	Globalisation and blood safety.
002D82 (2009)	M. Faber [États-Unis] ; B. Dietzschold [États-Unis] ; J. Li [États-Unis]	Immunogenicity and Safety of Recombinant Rabies Viruses Used for Oral Vaccination of Stray Dogs and Wildlife
002E12 (2009)	Susan L. Stramer [États-Unis] ; F. Blaine Hollinger [États-Unis] ; Louis M. Katz [États-Unis] ; Steven Kleinman [États-Unis] ; Peyton S. Metzel [États-Unis] ; Kay R. Gregory [États-Unis] ; Roger Y. Dodd [États-Unis]	Emerging infectious disease agents and their potential threat to transfusion safety
002F31 (2009)	Albert Farrugia [Australie]	Globalisation and blood safety
003308 (2008)	A. Gröner [Allemagne]	Pathogen safety of plasma‐derived products – Haemate® P/Humate‐P®
003381 (2008)	Frans J. M. Smulders [Autriche] ; Ivar V Gsholm [Suède] ; Hannu Korkeala [Finlande]	Food-borne zoonoses, the EU zoonosis legislation and the prospects for food safety and consumer protection during primary animal production

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "safety" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "safety" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    safety
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021